You have 9 free searches left this month | for more free features.

EC-T

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew

Not yet recruiting
  • Platelet Aggregation
  • +4 more
  • Aspirin 81Mg Ec Tab twice daily for 7 days
  • +2 more
  • Montréal, Quebec, Canada
    Montreal Heart Institute
Jan 25, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • +2 more
  • Biopsy
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Aug 7, 2023

Breast Cancer Trial in Beijing (EC-T, TP)

Completed
  • Breast Cancer
  • Beijing, China
    Cancer Institute & Hospital Chinese Academy of Medical Sciences
Feb 5, 2021

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Diabetes, Type 2 Trial in Montréal (Aspirin 80 mg EC Tab)

Recruiting
  • Diabetes Mellitus, Type 2
  • Aspirin 80 mg EC Tab
  • Montréal, Quebec, Canada
    Montreal Heart Institute
Nov 2, 2021

Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom

Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +3 more
Dec 19, 2022

Breast Cancer Invasive Trial in Shanghai (Pyrotinib, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Breast Cancer Invasive
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Breast Cancer Trial in Shanghai (Paclitaxel, Carboplatin, Epirubicin)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital Affiliated to Fudan University
Mar 5, 2020

Anal Dysplasia, Human Papillomavirus, Anal Cancer Trial in Vancouver, Ottawa, Toronto (The Hyfrecator ® 2000 Electrosurgical

Terminated
  • Anal Dysplasia
  • +2 more
  • The Hyfrecator ® 2000 Electrosurgical System
  • Observation Alone
  • Vancouver, British Columbia, Canada
  • +3 more
Jun 9, 2022

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Urothelial Carcinoma Trial in United States (disitamab vedotin, pembrolizumab)

Recruiting
  • Urothelial Carcinoma
  • Los Angeles, California
  • +17 more
Jan 3, 2023

Smoking Cessation, Electronic Cigarette Use Trial in Islamabad (Electronic Cigarette (EC), Nicotine Replacement Therapy)

Not yet recruiting
  • Smoking Cessation
  • Electronic Cigarette Use
  • Electronic Cigarette (EC)
  • Nicotine Replacement Therapy
  • Islamabad, Pakistan
    Health Research Consulting
Sep 26, 2023

Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)

Enrolling by invitation
  • Choroideremia
  • X-Linked Retinitis Pigmentosa
  • BIIB111
  • BIIB112
  • Los Angeles, California
  • +22 more
Apr 20, 2022

Ergonomics Trial in Odense (Ergonomic chinrest used with low shoulder rest (EC))

Completed
  • Ergonomics
  • Ergonomic chinrest used with low shoulder rest (EC)
  • Odense, Denmark
    University of Southern Denmark
Nov 7, 2022

Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)

Active, not recruiting
  • Aortic Valve Disease
  • Aortic Valve Disorder
  • Trifecta GT (Glide Technology) Valve
  • Rochester, Minnesota
  • +26 more
Mar 10, 2022

Stomach Tumors, Esophageal Tumors Trial in Japan (Amivantamab)

Recruiting
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Chuo-Ku, Japan
  • +10 more
Jan 27, 2023

Breast Tumor Trial in China (Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin)

Recruiting
  • Breast Neoplasm
  • Epirubicin plus Cyclophosphamide
  • +2 more
  • Fuding, Fujian, China
  • +26 more
Mar 28, 2022